Loading...
Please wait
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL - Two Onc Docs | OndaCast
Podcast
Laden...
Waves
Explore
Library
Vibes
Podcasts
Audiobooks
Podcast
Back to Two Onc Docs
EPISODE
December 16, 2025
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Von
Two Onc Docs
•
Sam and Karine
Folge abspielen
Boost
Show-Notizen
This week’s episode will be focusing on an update of a late-breaking abstract presented at ASH 2025 this past week: the Phase 3 BRUIN-CLL 313 trial looking at Pirtobrutinib vs Bendamustine/Rituximab in 1L Chronic Lymphocytic Leukemia (CLL).
Das könnte dir auch gefallen
Waves
Explore
Library
Vibes
Podcasts
Audiobooks
